X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $90,916.56 +1.35%
Ethereum $3,113.75 +1.97%
BNB $898.86 +0.61%
Optimism $0.31 -1.12%
Arbitrum $0.21 +1.44%
Solana $134.78 +1.43%
Polygon $0.22 +2.77%
Cosmos $2.21 -1.75%
Avalanche $13.67 +2.44%

Bitcoin $90,916.56 +1.35%
Ethereum $3,113.75 +1.97%
BNB $898.86 +0.61%
Optimism $0.31 -1.12%
Arbitrum $0.21 +1.44%
Solana $134.78 +1.43%
Polygon $0.22 +2.77%
Cosmos $2.21 -1.75%
Avalanche $13.67 +2.44%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed